175 related articles for article (PubMed ID: 32953595)
1. Predictive factors of contralateral occult carcinoma in patients with papillary thyroid carcinoma: a retrospective study.
Chen X; Zhong Z; Song M; Yuan J; Huang Z; Du J; Liu Y; Wu Z
Gland Surg; 2020 Aug; 9(4):872-878. PubMed ID: 32953595
[TBL] [Abstract][Full Text] [Related]
2. Risk Factors for Contralateral Occult Carcinoma in Patients With Unilateral Papillary Thyroid Carcinoma: A Retrospective Study and Meta-Analysis.
Zhang F; Zheng B; Yu X; Wang X; Wang S; Teng W
Front Endocrinol (Lausanne); 2021; 12():675643. PubMed ID: 34322091
[TBL] [Abstract][Full Text] [Related]
3. Predictive factors and pattern of central lymph node metastasis in unilateral papillary thyroid carcinoma.
Ji YB; Yoo HS; Song CM; Park CW; Lee CB; Tae K
Auris Nasus Larynx; 2016 Feb; 43(1):79-83. PubMed ID: 26441368
[TBL] [Abstract][Full Text] [Related]
4. Delphian lymph node metastasis predicts occult contralateral carcinoma for unilateral papillary thyroid carcinoma patients with contralateral benign nodules.
Chen ML; Xu D; Yan XQ; Xie BJ
Asian J Surg; 2023 Jan; 46(1):156-159. PubMed ID: 35277319
[TBL] [Abstract][Full Text] [Related]
5. Risk factors stratifying malignancy of nodules in contralateral thyroid lobe in patients with pre-operative ultrasound indicated unilateral papillary thyroid carcinoma: A retrospective analysis from single centre.
Lv T; Zhu C; Di Z
Clin Endocrinol (Oxf); 2018 Feb; 88(2):279-284. PubMed ID: 29083503
[TBL] [Abstract][Full Text] [Related]
6. Management of Clinically Solitary Papillary Thyroid Carcinoma Patients According to Risk-Scoring Model for Contralateral Occult Carcinoma.
Feng JW; Ye J; Wu WX; Pan H; Qin AC; Jiang Y; Wu BQ
Front Endocrinol (Lausanne); 2020; 11():553577. PubMed ID: 33133013
[TBL] [Abstract][Full Text] [Related]
7. Predictive factors for ipsilateral or contralateral central lymph node metastasis in unilateral papillary thyroid carcinoma.
Koo BS; Choi EC; Yoon YH; Kim DH; Kim EH; Lim YC
Ann Surg; 2009 May; 249(5):840-4. PubMed ID: 19387316
[TBL] [Abstract][Full Text] [Related]
8. Risk Factors for Contralateral Occult Papillary Thyroid Carcinoma in Patients with Clinical Unilateral Papillary Thyroid Carcinoma: A Case-Control Study.
Yihao L; Shuo L; Pu X; Zipeng W; Hanlin S; Qungang C; Yongfei W; Detao Y
Int J Endocrinol; 2022; 2022():5112985. PubMed ID: 35800226
[TBL] [Abstract][Full Text] [Related]
9. Predictive factors of contralateral paratracheal lymph node metastasis in unilateral papillary thyroid carcinoma.
Wei T; Chen R; Zou X; Liu F; Li Z; Zhu J
Eur J Surg Oncol; 2015 Jun; 41(6):746-50. PubMed ID: 25882035
[TBL] [Abstract][Full Text] [Related]
10. Preoperative BRAF mutation is predictive of occult contralateral carcinoma in patients with unilateral papillary thyroid microcarcinoma.
Zhou YL; Zhang W; Gao EL; Dai XX; Yang H; Zhang XH; Wang OC
Asian Pac J Cancer Prev; 2012; 13(4):1267-72. PubMed ID: 22799316
[TBL] [Abstract][Full Text] [Related]
11. Performing contralateral central lymph node dissection in papillary thyroid carcinoma: a decision approach.
Chae BJ; Jung CK; Lim DJ; Song BJ; Kim JS; Jung SS; Bae JS
Thyroid; 2011 Aug; 21(8):873-7. PubMed ID: 21745104
[TBL] [Abstract][Full Text] [Related]
12. [Clinical analysis of lymphocytic thyroiditis coexistent with papillary thyroid carcinoma].
Wang SX; She ZQ; An CM; Zhang XW; Li ZJ; Tang PZ
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2016 Apr; 51(4):277-81. PubMed ID: 27095720
[TBL] [Abstract][Full Text] [Related]
13. The BRAFT1799A mutation is not associated with occult contralateral carcinoma in patients with unilateral papillary thyroid microcarcinoma.
Wan HF; Zhang B; Yan DG; Xu ZG
Asian Pac J Cancer Prev; 2015; 16(7):2947-51. PubMed ID: 25854387
[TBL] [Abstract][Full Text] [Related]
14. Occult contralateral central lymph node metastases in papillary thyroid carcinoma with unilateral lymph node metastasis in the lateral neck.
Koo BS; Choi EC; Park YH; Kim EH; Lim YC
J Am Coll Surg; 2010 Jun; 210(6):895-900. PubMed ID: 20510797
[TBL] [Abstract][Full Text] [Related]
15. Predicting Factors for Bilaterality in Papillary Thyroid Carcinoma with Tumor Size <4 cm.
Kim SK; Park I; Woo JW; Lee JH; Choe JH; Kim JH; Kim JS
Thyroid; 2017 Feb; 27(2):207-214. PubMed ID: 27750022
[TBL] [Abstract][Full Text] [Related]
16. High-risk factors for lymph node metastasis in contralateral central compartment in unilateral papillary thyroid carcinoma(cT1N0).
Zhou B; Qin J
Eur J Surg Oncol; 2021 Apr; 47(4):882-887. PubMed ID: 33092967
[TBL] [Abstract][Full Text] [Related]
17. Risk factor for contralateral occult carcinoma in patients with unilateral papillary thyroid carcinoma.
Ahn HR; Kang SY; Youn HJ; Jung SH
Korean J Clin Oncol; 2020 Jun; 16(1):33-38. PubMed ID: 36945305
[TBL] [Abstract][Full Text] [Related]
18. [Prediction of occult carcinoma in contralateral nodules for unilateral papillary thyroid carcinoma].
Wan H; Zhang B; Yan D; Xu Z
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2014 Nov; 49(11):881-4. PubMed ID: 25598363
[TBL] [Abstract][Full Text] [Related]
19. Predictors of lymph nodes posterior to the right recurrent laryngeal nerve metastasis in patients with papillary thyroid carcinoma: A retrospective study.
Yuan J; Li J; Chen X; Zhong Z; Chen Z; Yin Y; Du J; Cong S; Wu Z
Medicine (Baltimore); 2017 Sep; 96(35):e7908. PubMed ID: 28858110
[TBL] [Abstract][Full Text] [Related]
20. Prediction of occult central lymph node metastasis in papillary thyroid carcinoma by preoperative BRAF analysis using fine-needle aspiration biopsy: a prospective study.
Joo JY; Park JY; Yoon YH; Choi B; Kim JM; Jo YS; Shong M; Koo BS
J Clin Endocrinol Metab; 2012 Nov; 97(11):3996-4003. PubMed ID: 22930785
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]